ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Basic/Clinical Science Session

Preserving the Tuft: New Concepts in Glomerular Disease Therapeutics, Including the Michelle P. Winn, MD, Endowed Lectureship

October 22, 2020 | 10:30 AM - 12:30 PM

Location: Live-Streamed

Session Description

Therapeutic targets for glomerular disease remain scarce, but recent advances bode well for improved patient outcomes and treatment options in the near future. This session explores emerging concepts in the treatment of glomerular disease with a focus on precision-based approaches.

ASN gratefully acknowledges Duke University School of Medicine, the school's Division of Nephrology, and several individuals for support of the Michelle P. Winn, MD, Endowed Lectureship.

Support is provided by an educational grant from Chinook Therapeutics, Inc.

Learning Objective(s)

  • Define novel and emerging therapeutic targets for primary glomerular disease
  • Describe the specificity, efficacy, and mechanism of action of novel therapeutic agents for glomerular disease

Learning Pathway(s)

  • Glomerular Diseases


  • Dawn J. Caster, MD, FASN
  • Rasheed A. Gbadegesin, MD, MBBS, FASN


  • Drug Targeting of the Podocyte Actin Cytoskeleton: The Michelle P. Winn, MD, Endowed Lectureship
    10:30 AM - 11:00 AM
    Mario Schiffer, MD, MBA
  • Targeting Podocyte Histone Deacetylases
    11:00 AM - 11:30 AM
    Shuta Ishibe, MD 
  • Therapeutic Targeting of APOL1: Rationale and Current Strategies
    11:30 AM - 12:00 PM
    Opeyemi A. Olabisi, MD, PhD 
  • Targeting the Complement System in Glomerular Disease: Novel Concepts
    12:00 PM - 12:30 PM
    Nicole Van De Kar, MD, PhD